Abgenix, Inc. (ABGX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Abgenix, Inc. (ABGX)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: keokalani'nui who wrote (201)	5/30/2003 7:12:35 PM
From: Miljenko Zuanic	of 590

Maybe, but would you benefit? Message 18989104 <<Abgenix (ABGX:Nasdaq - news - commentary - research - analysis), for example, rose 7% Friday morning after a note from CIBC analyst Matt Geller repeated what he described as the "encouraging response data" on the company's cancer drug from the ASCO abstract -- information that was supposed to be withheld until the weekend. Shares drooped in later trading.>> Due to last minute abstracts leak, IMCL is up 12 point and ABGX 1 point for May. Now, regardless what is written in abstracts, if one use RCC as indicator, ABX-EGF should have equal if not better data than C225. Well, market do not think it is the case! Analyst were wrong on Avastin, and maybe they are wrong again? Maybe not? Miljenko

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next